Previous studies have shown that E7050 may overcome HGF-induced resistance in lung cancer cells carrying epidermal growth factor receptor (EGFR) mutations by blocking the Met/Gab1/PI3K/Akt signaling pathway. Here, EGFR is linked to lung carcinoma.